Authors: Qi, L Ostrand-Rosenberg, S

Citation: L. Qi et S. Ostrand-rosenberg, H2-O inhibits presentation of bacterial superantigens, but not endogenous self antigens, J IMMUNOL, 167(3), 2001, pp. 1371-1378

Authors: Qi, L Ostrand-Rosenberg, S

Citation: L. Qi et S. Ostrand-rosenberg, MHC class II presentation of endogenous tumor antigen by cellular vaccinesdepends on the endocytic pathway but not H2-M, TRAFFIC, 1(2), 2000, pp. 152-160

Authors: Pulaski, BA Clements, VK Pipeling, MR Ostrand-Rosenberg, S

Citation: Ba. Pulaski et al., Immunotherapy with vaccines combining MHC class II/CD80(+) tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma, CANCER IMMU, 49(1), 2000, pp. 34-45

Authors: Ostrand-Rosenberg, S Grusby, MJ Clements, VK

Citation: S. Ostrand-rosenberg et al., Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primaryand metastatic mammary carcinoma, J IMMUNOL, 165(11), 2000, pp. 6015-6019

Authors: Qi, L Rojas, JM Ostrand-Rosenberg, S

Citation: L. Qi et al., Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo, J IMMUNOL, 165(10), 2000, pp. 5451-5461

Authors: Pulaski, BA Terman, DS Khan, S Muller, E Ostrand-Rosenberg, S

Citation: Ba. Pulaski et al., Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model, CANCER RES, 60(10), 2000, pp. 2710-2715